Jenny S Guadamuz
Overview
Explore the profile of Jenny S Guadamuz including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
40
Citations
289
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Holt H, Calip G, Peterson C, MacLaughlan David S, Geller S, Guadamuz J
Cancer Causes Control
. 2025 Jan;
PMID: 39847161
Purpose: Older Black women and women living in areas of low socioeconomic status (SES) diagnosed with cervical cancer (CC) have worse overall survival (OS). The objective was to investigate associations...
2.
Guadamuz J, Alexander G, Kanter G, Qato D
Health Aff (Millwood)
. 2024 Dec;
43(12):1703-1711.
PMID: 39626155
In recent years, federal and state policy makers have expressed concern about retail pharmacy closures throughout the US. However, there is a dearth of timely information on the extent of...
3.
Guadamuz J, Wang X, Altomare I, Camelo Castillo W, Sarkar S, Mamtani R, et al.
JNCI Cancer Spectr
. 2024 Sep;
8(5).
PMID: 39271476
Background: Although racially and ethnically minoritized populations are less likely to participate in cancer trials, it is unknown whether social determinants of health (SDOH) explain these inequities. Here we identify...
4.
Mohyuddin G, Guadamuz J, Ascha M, Chiu B, Patel P, Sweiss K, et al.
Blood Adv
. 2024 Aug;
8(21):5539-5541.
PMID: 39207867
No abstract available.
5.
Altomare I, Wang X, Kaur M, Guadamuz J, Falk S, Xiao F, et al.
JNCI Cancer Spectr
. 2024 Jul;
8(4).
PMID: 39041606
Background: Expanding access to clinical trials in community settings is a potential approach to addressing disparities in accrual of historically underrepresented populations. However, little is known about the characteristics of...
6.
Qato D, Guadamuz J, Myerson R
JAMA
. 2024 Jul;
332(6):504-506.
PMID: 38953733
No abstract available.
7.
Qato D, Myerson R, Shooshtari A, Guadamuz J, Alexander G
JAMA Netw Open
. 2024 Jun;
7(6):e2418620.
PMID: 38922616
Importance: The US Supreme Court Dobbs v Jackson Women's Health Organization decision allowed states to strengthen restrictions on abortion access, triggering the closure of family planning clinics and leading to...
8.
Kaur M, Frahm F, Lu Y, Ascha M, Guadamuz J, Dotan E, et al.
NEJM Evid
. 2024 May;
3(4):EVIDoa2300236.
PMID: 38771994
Background: Certain populations have been historically underrepresented in clinical trials. Broadening eligibility criteria is one approach to inclusive clinical research and achieving enrollment goals. How broadened trial eligibility criteria affect...
9.
Calip G, Hoskins K, Guadamuz J
JAMA Netw Open
. 2024 May;
7(5):e249402.
PMID: 38722634
No abstract available.
10.
Pittell H, Calip G, Pierre A, Ryals C, Guadamuz J
Breast Cancer Res Treat
. 2024 May;
206(2):411-423.
PMID: 38702585
Purpose: Racialized economic segregation, a form of structural racism, may drive persistent inequities among patients with breast cancer. We examined whether a composite area-level index of racialized economic segregation was...